|









|
 |
Hong-Gang Wang, Ph.D.
Associate Professor in the Interdisciplinary Oncology Program
Member-in-Residence of the Moffitt Cancer Center
E-mail:
Hong-Gang.Wang@moffitt.org
Phone: (813) 745-6764
|
Training
B.Sc.: University of Tsukuba, Japan, 1987.
Ph.D.: University of Tsukuba, Japan, 1992.
Postdoctoral Fellow: The Burnham Institute, La Jolla, CA, 1993-1998.
Research
Interests
Much of the work in our laboratory is concerned with understanding of the mechanisms that control programmed cell death and cell cycle checkpoints in the context of oncogenesis. In addition, development of small molecules that directly target the core components of the cell death machinery for drug discovery is also one of the major research interests of our laboratory.
Search
for publications by: 
This
search will be conducted at the US National Library of Medicine (NLM) and PubMed.
Selected Publications:
Yamaguchi H and Wang H-G: Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase-3 in thapsigargin-treated cells. Mol. Cell. Biol. 26: 569-579, 2006.
Takahashi Y, Karbowski M, Yamaguchi H, Kazi A, Wu J, Sebti SM, Youle RJ, and Wang H-G: Loss of bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol. Cell. Biol. 25: 9369-9382, 2005.
Hirai H and Wang H-G: A role of the C-terminal region of human Rad9 (hRad9) in nuclear transport of the hRad9 checkpoint complex. J. Biol. Chem. 277: 25722-25727, 2002.
Yamaguchi H and Wang H-G: The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20: 7779-7786, 2001.
Komatsu K, Miyashita T, Hang H, Hopkins KM, Zheng W, Cuddeback S, Yamada M, Lieberman HB, Wang H-G: Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat. Cell Biol. 2(1): 1-6, 2000.
-
Back to Main Faculty Page -
|
|